Impact Factor
2.25
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
0.90
71 total citations
h5-index
9
h5 depth signal
Cited share
52.3%
46 of 88
Total citations
71
Citation footprint
Metric signal
0.71
External metric anchor
Self-citation
2.8%
2 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
Poland
141
China
56
Turkey
56
Egypt
17
Italy
16
Citing Fields of Research
Oncology
122
Cancer & Development
69
Musculoskeletal & Nerve Cancer
67
Breast Cancer
60
Immunology
44
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
755
Articles tracked across the journal lifetime
Indexed publication set
88
46 cited publications
Last 12 months
32
8.0 publications/month
Open access share
78.1%
25 OA publications in the last year
Leading citing country
Poland
141 citing publications
Leading citing field
Oncology
122 citing publications
Latest tracked publication
16 October 2026
10 recent records available
Coverage & Indexing History
v45n1, 1994-
v45n1, 1994-
Active Coverage
Research Focus & Classification
Indexed Subjects
Oncology
Breast Cancer
Lung Cancer
Dermatology
Cancer & Development
Clinical Laboratory Science
Immunology
Issuing & Sponsoring Bodies
Contributor
Polskie Towarzystwo Patologów
Broad Categories
Pathology
Genetics & Genomics
Noncoding RNA
Cancer & Development
Breast Cancer
Endocrinology & Metabolism
Musculoskeletal & Nerve Cancer
Cancer, Autophagy & Apoptosis
MeSH Descriptors
Pathology
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.5114/pjp/221017
Open DOI
Clinical and pathological analysis of invasive mucinous micropapillary carcinoma of the breast: a series of case reports
The aim of the study was to analyse the clinicopathological features of invasive mucinous micropapillary carcinoma (MUMPC), a rare breast cancer variant. We retrospectively reviewed 7 MUMPC cases diagnosed in 2017–2024, evaluating clinic...
02
DOI 10.5114/pjp/226873
Open DOI
Extramural venous invasion as an independent predictor of lymph node metastasis in colon adenocarcinoma: a multivariate analysis
Introduction: Lymph node metastasis (LNM) is a key determinant of prognosis and treatment decisions in colon adenocarcinoma. Among histopathological features associated with tumor aggressiveness, extramural venous invasion (EMVI) has bee...
03
DOI 10.5114/pjp/217768
Open DOI
Case report of locally advanced basal cell carcinoma with complete response and long-term follow-up with vismodegib therapy
Basal cell carcinoma (BCC) is the most common skin malignancy. For locally advanced or metastatic cases not amenable to surgery or radiotherapy, Hedgehog pathway inhibitors represent an effective treatment option. A 50-year-old female, p...
04
DOI 10.5114/pjp.2026.162566
Open DOI
Review of a Decade of IHC Quality – Expectations, Disappointments and Challenges in Commonly Used Assays Based on NordiQC Experience
Immunohistochemistry (IHC) has undergone substantial expansion during the past decades, with an increasing number of assays becoming essential to routine diagnostic, prognostic, and predictive pathology. Parallel to this development, ext...
05
DOI 10.5114/pjp.2026.162567
Open DOI
Using large-scale tissue microarray resources for the identification and evaluation of old, new, and novel targets for surgical pathology
Immunohistochemistry (IHC) is essential in diagnostic pathology, but antibody reliability is often limited by insufficient validation and high variability between clones. Conventional validation approaches normally use only few tissues o...
06
DOI 10.5114/pjp.2026.162568
Open DOI
Ancillary tests in diagnostic cytology. On the example of the recommendation given by the World Health Organization in soft tissue tumors
Fine needle aspiration despite being an inexpensive, rapid, accurate and non-invasive diagnostic practice, particularly when used in oncology, is frequently underutilized. The World Health Organization – International Academy of Cytology...
07
DOI 10.5114/pjp.2026.162569
Open DOI
New and emerging entities of uterine mesenchymal tumours in the era of molecular testing
Uterine mesenchymal tumours represent a group of heterogeneous tumours, the classification of which is evolving, especially in the context of a broader use of molecular testing. Some entities can be diagnosed based on the combination of ...
08
DOI 10.5114/pjp.2026.162570
Open DOI
Immunohistochemistry in placental pathology
Although the clinical background, gross and hematoxylin-eosin examination usually suffice for the placental diagnosis, immunohistochemistry (IHC) is essential in many cases, particularly in high-risk pregnancy. The double E-cadherin/CD34...
09
DOI 10.5114/pjp.2026.162571
Open DOI
Immunohistochemical and molecular diagnostics tailoring personalised ovarian cancer therapy
Ovarian cancer remains the most lethal gynaecological malignancy, and it exhibits substantial histologic and molecular heterogeneity. Traditional systemic therapies have produced only modest survival gains. Integration of immunohistochem...
10
DOI 10.5114/pjp.2026.162572
Open DOI
Challenging cases of Epstein-Barr virus positive lymphomas
Epstein-Barr virus (EBV)-associated lymphomas can develop in both immuno- competent and immunocompromised patients, such as those with human immunodeficiency virus (HIV) infection, other primary or acquired immunodeficiencies, or post tr...
Bibliographical & Catalog Notes
Title from cover.
Also issued online
Articles chiefly in English with some Polish; summaries in English.